Young-onset Parkinsonism in a Hong Kong Chinese man with adult-onset Hallervorden-Spatz syndrome

International Journal of Neuroscience

Volumn 121, Issue 4, 2011, Pages 224-227

  Mak, Chloe Miu ^a   Sheng, Bun ^a   Lee, Hencher Han Chih ^a   Lau, Kwok Kwong ^a   Chan, Wing Tak ^a   Lam, Ching Wan ^b   Chan, Yan Wo ^a  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Hallervorden Spatz disease; Hong Kong Chinese; PANK2; pantothenate kinase 2; young onset parkinsonism

Indexed keywords

PANTOTHENATE KINASE 2;

ADULT; ANAMNESIS; ARTICLE; BASAL GANGLION; CASE REPORT; CHINESE; DNA SEQUENCE; EXTRAPYRAMIDAL SYMPTOM; GENE MUTATION; HETEROZYGOSITY; HONG KONG; HUMAN; MALE; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; ONSET AGE; PARKINSONISM; PHENOTYPE; POLYMERASE CHAIN REACTION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HONG KONG; HUMANS; MALE; MUTATION; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; PARKINSONIAN DISORDERS; PHENOTYPE; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);

EID: 79951926412     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2010.542843     Document Type: Article

References (18)

1. Aggarwal, A., Schneider, S. A., Houlden, H., Silverdale, M., Paudel, R., Paisan-Ruiz, C., et al. (2010). Indian-subcontinent NBIA: Unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms. Movement Disorders, 25(10), 1424-1431.
2. Baumeister, F. A., Auer, D. P., et al. (2005). The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden-Spatz syndrome. Neuropediatrics, 36(3), 221-222. (Pubitemid 41117122)
3. Gregory, A., Polster, B. J., & Hayflick, S. J. (2009). Clinical and genetic delineation of neurodegeneration with brain iron accumulation. Journal of Medical Genetics, 46(2), 73-80.
4. Hallervorden, J., & Spatz, H. (1922). Eigenartige Erkrankun im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus und der Substantia nigra. Journal of Neurology & Psychiatry, 79, 254-302.
5. Hartig, M. B., Hortnagel, K., Garavaglia, B., Zorzi, G., Kmiec, T., Klopstock, T., et al. (2006). Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Annals of Neurology, 59(2), 248-256. (Pubitemid 43202477)
6. Hayflick, S. J., Westaway, S. K., Levinson, B., Zhou, B., Johnson, M. A., Ching, K. H., et al. (2003). Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. The New England Journal of Medicine, 348(1), 33-40. (Pubitemid 36026344)
7. Van der Knaap, M. S., Valk, J., de Neeling, N., & Nauta, J. J. (1991). Pattern recognition in magnetic resonance imaging of white matter disorders in children and young adults. Neuroradiology, 33(6), 478-493.
8. Rump, P., Lemmink, H. H., Verschuuren-Bemelmans, C. C., Grootscholten, P. M., Fock, J. M., Hayflick, S. J., et al. (2005). A novel 3-bp deletion in the PANK2 gene of Dutch patients with pantothenate kinase-associated neurodegeneration: Evidence for a founder effect. Neurogenetics, 6(4), 201-207. (Pubitemid 41720892)
9. Rutledge, J. N., Hilal, S. K., Silver, A. J., Defendini, R., & Fahn, S. (1988).Magnetic resonance imaging of dystonic states. Advances in Neurology, 50, 265-275.
10. Savoiardo, M., Halliday, W. C., Nardocci, N., Strada, L., D'Incerti, L., Angelini, L., et al. (1993). Hallervorden-Spatz disease: MR and pathologic findings. AJNR - American Journal of Neuroradiology, 14(1), 155-162. (Pubitemid 23055937)
11. Seo, J. H., Song, S. K., & Lee, P. H. (2009). A novel PANK2 mutation in a patient with atypical pantothenate-kinase-associated neurodegeneration presenting with adult-onset parkinsonism. The Journal of Clinical Neurology, 5(4), 192-194.
12. Song, X. W., Wang, Y. L., Shi, Y. W., Deng, W. Y., Chen, S. Q., Lin, H., et al. (2009). Clinical manifestations and detection of pantothenate kinase 2 gene mutation in a patient with Hallervorden-Spatz syndrome. Zhonghua Yi Xue Za Zhi, 89(47), 3320-3323.
13. Swaiman, K. F. (1991). Hallervorden-Spatz syndrome and brain iron metabolism. Archives of Neurology, 48(12), 1285-1293.
14. Swaiman, K. F. (2001). Hallervorden-Spatz syndrome. Pediatric Neurology, 25(2), 102-108.
15. Valentino, P., Annesi, G., Ciro Candiano, I. C., Annesi, F., Civitelli, D., Tarantino, P., et al. (2006). Genetic heterogeneity in patients with pantothenate kinase-associated neurodegeneration and classic magnetic resonance imaging eye-of-the-tiger pattern. Movement Disorders, 21(2), 252-254.
16. Vasconcelos, O. M., Harter, D. H., Duffy, C., McDonough, B., Seidman, J. G., Seidman, C., et al. (2003). Adult Hallervorden-Spatz syndrome simulating amyotrophic lateral sclerosis. Muscle & Nerve, 28(1), 118-122. (Pubitemid 36775969)
17. Zhang, Y. H., Tang, B. S., Zhao, A. L., Xia, K., Long, Z. G., Guo, J. F., et al. (2005). Novel compound heterozygous mutations in the PANK2 gene in a Chinese patient with atypical pantothenate kinase-associated neurodegeneration. Movement Disorders, 20(7), 819-821. (Pubitemid 41227148)
18. Zhou, B., Westaway, S. K., Levinson, B., Johnson, M. A., Gitschier, J., & Hayflick, S. J. (2001). A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nature Genetics, 28(4), 345-349. (Pubitemid 32702423)